
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.70 | 0.70 | 0.00 |
Shares | 99.30 | 99.30 | 0.00 |
Other | 0.01 | 0.01 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.87 | 19.99 |
Price to Book | 4.17 | 3.94 |
Price to Sales | 2.33 | 2.31 |
Price to Cash Flow | 15.13 | 15.60 |
Dividend Yield | 1.87 | 1.43 |
5 Years Earnings Growth | 9.91 | 11.18 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.63 | 94.42 |
Basic Materials | 0.31 | 2.03 |
Consumer Defensive | 0.04 | 3.26 |
Financial Services | 0.02 | 9.13 |
Number of long holdings: 189
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.46 | 747.12 | +1.28% | |
UnitedHealth | US91324P1021 | 5.70 | 304.72 | +0.93% | |
J&J | US4781601046 | 5.19 | 155.40 | +0.12% | |
AbbVie | US00287Y1091 | 4.79 | 186.99 | +0.47% | |
Novo Nordisk B | DK0062498333 | 3.63 | 475.0 | +4.72% | |
Roche Holding Participation | CH0012032048 | 3.10 | 264.70 | -0.30% | |
Abbott Labs | US0028241000 | 3.07 | 133.61 | +0.02% | |
Merck&Co | US58933Y1055 | 3.03 | 76.25 | -0.77% | |
Novartis | CH0012005267 | 2.84 | 95.08 | +1.12% | |
AstraZeneca | GB0009895292 | 2.64 | 10,574.0 | -1.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.32B | -9.46 | 8.17 | 13.30 | ||
Legal General US Index Trust C Dist | 867.41M | -9.51 | 8.16 | 13.29 | ||
Legal General US Index Trust I Acc | 1.5B | -9.51 | 8.10 | 13.25 | ||
Legal General US Index Trust I Dist | 1.59B | -9.52 | 8.10 | 13.25 | ||
Legal General US Index Trust F Acc | 522.93K | -13.39 | 7.40 | 12.83 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review